CH601295A5 - - Google Patents

Info

Publication number
CH601295A5
CH601295A5 CH774174A CH774174A CH601295A5 CH 601295 A5 CH601295 A5 CH 601295A5 CH 774174 A CH774174 A CH 774174A CH 774174 A CH774174 A CH 774174A CH 601295 A5 CH601295 A5 CH 601295A5
Authority
CH
Switzerland
Application number
CH774174A
Inventor
Claude F Spencer
Robert J Alaimo
Original Assignee
Morton Norwich Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morton Norwich Products Inc filed Critical Morton Norwich Products Inc
Publication of CH601295A5 publication Critical patent/CH601295A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CH774174A 1973-06-06 1974-06-06 CH601295A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US367499A US3868378A (en) 1973-06-06 1973-06-06 Imidazo {8 4,5-f{9 {0 quinolin-9-ols

Publications (1)

Publication Number Publication Date
CH601295A5 true CH601295A5 (xx) 1978-07-14

Family

ID=23447421

Family Applications (1)

Application Number Title Priority Date Filing Date
CH774174A CH601295A5 (xx) 1973-06-06 1974-06-06

Country Status (12)

Country Link
US (1) US3868378A (xx)
JP (1) JPS5019776A (xx)
BE (1) BE816005A (xx)
CH (1) CH601295A5 (xx)
DE (1) DE2427411A1 (xx)
DK (1) DK133105C (xx)
FR (1) FR2232319B1 (xx)
GB (1) GB1409871A (xx)
IL (1) IL44283A (xx)
NL (1) NL7403667A (xx)
SE (1) SE391927B (xx)
ZA (1) ZA741268B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5265325A (en) * 1975-11-26 1977-05-30 Kogyo Gijutsuin Ball valve
FR2391214A1 (fr) * 1977-05-20 1978-12-15 Chauvin Blache Sa Labo Nouveaux derives de l'indazole, leur procede de preparation et leur application en therapeutique
US4716168A (en) * 1985-01-08 1987-12-29 Norwich Eaton Pharmaceuticals, Inc. Imidazo(4,5-f)quinolines useful as immunomodulating agents
US7622592B2 (en) * 2002-11-01 2009-11-24 Merck & Co., Inc. Carbonylamino-benzimidazole derivatives as androgen receptor modulators
WO2016083490A1 (en) * 2014-11-27 2016-06-02 Remynd Nv Compounds for the treatment of amyloid-associated diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
US3636216A (en) * 1968-09-26 1972-01-18 Salsbury Lab Coccidiosis control with quinalinol derivatives
US3506667A (en) * 1969-05-01 1970-04-14 Warner Lambert Pharmaceutical Furo quinoline carboxylates
CA942310A (en) * 1969-07-09 1974-02-19 Mitsuo Nakashita Preparation of n-substituted 6,7-methylenedioxy-4-quinolone derivatives
GB1356937A (en) * 1970-08-27 1974-06-19 Wellcome Found Pyrimido-isoquinolines
US3790576A (en) * 1972-03-20 1974-02-05 Parke Davis & Co 9 substituted 4,9-dihydro-1,3,4,4-tetraalkyl-1h-pyrazolo(3,4-b)quinolines

Also Published As

Publication number Publication date
JPS5019776A (xx) 1975-03-01
DK133105C (da) 1976-08-23
DK133105B (da) 1976-03-22
SE7405654L (xx) 1974-12-09
IL44283A0 (en) 1974-05-16
US3868378A (en) 1975-02-25
BE816005A (fr) 1974-12-06
AU6910074A (en) 1975-11-20
GB1409871A (en) 1975-10-15
DK302174A (xx) 1975-02-03
DE2427411A1 (de) 1975-03-13
NL7403667A (xx) 1974-12-10
FR2232319A1 (xx) 1975-01-03
ZA741268B (en) 1975-09-24
SE391927B (sv) 1977-03-07
IL44283A (en) 1976-12-31
FR2232319B1 (xx) 1978-03-24

Similar Documents

Publication Publication Date Title
AR201758A1 (xx)
AU476761B2 (xx)
AU465372B2 (xx)
AR201231Q (xx)
AU465453B2 (xx)
AU465434B2 (xx)
AU450229B2 (xx)
FR2232319B1 (xx)
AU477823B2 (xx)
AU461342B2 (xx)
AU476873B1 (xx)
AR201432A1 (xx)
AU477824B2 (xx)
AU447540B2 (xx)
AR210729A1 (xx)
AU1891376A (xx)
BG22532A1 (xx)
AU479496A (xx)
CH561394A5 (xx)
CH1122773A4 (xx)
CH1066074A4 (xx)
CH563496A5 (xx)
BG19983A1 (xx)
BG19384A1 (xx)
AU480894A (xx)

Legal Events

Date Code Title Description
PL Patent ceased